ESC Congress 2024: Key Findings on Lipoprotein(a), Endometriosis, and Cardiovascular Disease

New Insights from ESC Congress 2024

From August 30 through September 2, 2024, the European Society of Cardiology Congress in London brought together experts to discuss vital developments in cardiology. Among the most significant presentations was a study revealing that women with endometriosis have a 20% higher risk of long-term cardiovascular disease (CVD). Endometriosis, which affects approximately 10% of reproductive-age women, shares similar pathophysiological features with CVD.

Lipoprotein(a) and Cardiovascular Risk

Another noteworthy study evaluated lipoprotein(a) (Lp(a)), a type of low-density lipoprotein linked to increased risk for heart disease. Research indicated a direct correlation between serum levels of Lp(a) and the occurrence of myocardial infarction and coronary artery disease.

Highlighted Findings

• Women with endometriosis showed significant risks of acute myocardial infarction and other cardiovascular events.
• A study from Portugal connected higher Lp(a) levels to previous cardiac incidents.
• Understanding Lp(a) levels can aid in evaluating cardiovascular risks more accurately.

These findings underscore the importance of awareness surrounding the intersection of reproductive health and cardiovascular outcomes. More investigative inquiries and therapeutic strategies focusing on these patient groups are crucial as we advance in cardiovascular care.